Developability assessment as an early de-risking tool for biopharmaceutical development

ISSN： 2048-9145

Source： Pharmaceutical Bioprocessing, Vol.1, Iss.1, 2013-04, pp. : 29-50

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial [Hot Topic: De-risking the Discovery and Development of New Drugs from Bench to Clinic (Guest Editor: Sergey Ilyin)]

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 11, 2005-09 ,pp. : 1031-1031

Bentham Science Publishers

Access to resources Recommend Favorite

De-risking Scale-up of a High Shear Wet Granulation Process Using Latent Variable Modeling and Near-Infrared Spectroscopy

By Muteki Koji

Journal of Pharmaceutical Innovation, Vol. 6, Iss. 3, 2011-09 ,pp. : 142-156

Springer Publishing Company

Access to resources Recommend Favorite

De-Risking Bio-therapeutics for Possible Drug Interactions Using Cryopreserved Human Hepatocytes

Current Drug Metabolism, Vol. 13, Iss. 7, 2012-09 ,pp. : 923-929

Bentham Science Publishers

Access to resources Recommend Favorite

Design, Development, and Biopharmaceutical Properties of Buccoadhesive Compacts of Pentazocine

By Agarwal Varsha Mishra B.

Drug Development and Industrial Pharmacy, Vol. 25, Iss. 6, 1999-05 ,pp. : 701-709

Informa Healthcare

Access to resources Recommend Favorite

Advanced Development Strategies for Biopharmaceutical Cell Culture Processes

Current Pharmaceutical Biotechnology, Vol. 16, Iss. 11, 2015-01 ,pp. : 983-1001

Bentham Science Publishers

Access to resources Recommend Favorite